Opportunity ID: 69513

General Information

Document Type: Grants Notice
Funding Opportunity Number: DARPA-BAA-11-30
Funding Opportunity Title: Dialysis Like Therapeutics (DLT)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 12.910 — Research and Technology Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 08, 2011
Last Updated Date:
Original Closing Date for Applications: Apr 01, 2011 Important Dates:
Posting Date: February 8, 2011
Proposer’s Day Date: February 23, 2011 in Arlington, VA
Full Proposal Due Date: April 1, 2011
Current Closing Date for Applications: Apr 01, 2011 Important Dates:
Posting Date: February 8, 2011
Proposer’s Day Date: February 23, 2011 in Arlington, VA
Full Proposal Due Date: April 1, 2011
Archive Date: Oct 03, 2011
Estimated Total Program Funding:
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: DARPA – Microsystems Technology Office
Description: DARPA is soliciting
innovative research proposals to manage the life-threatening blood infection
known as sepsis. The goal of the Dialysis Like Therapeutics (DLT) program is to
develop a portable device capable of controlling relevant components in the entire blood volume on clinically relevant time scales. Reaching this goal is expected to require significant advances in sensing, complex fluid manipulation, separation of components from these fluids, and mathematical descriptions capable of providing predictive control over the closed-loop process. The envisioned device would save the lives of thousands of military patients each year by effectively treating sepsis and associated complications.

See full DARPA-BAA-11-30 attached.

Link to Additional Information: MTO Solicitations page
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Dr. Timothy Broderick

DARPA PM
Email:DARPA-BAA-11-30@darpa.mil

Version History

Version Modification Description Updated Date

Folder 69513 Full Announcement-1 -> approved proposer checklist.pdf

Folder 69513 Full Announcement-1 -> darpa-baa-11-30_dlt_final for posting_8feb11.pdf

Packages

Agency Contact Information: Dr. Timothy Broderick
DARPA PM
Email: DARPA-BAA-11-30@darpa.mil
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.910 PKG00031850 Feb 08, 2011 Apr 01, 2011 View

Package 1

Mandatory forms

69513 RR_SF424-1.1.pdf

Optional forms

69513 RR_FedNonFedBudget-1.1.pdf

69513 RR_FedNonFed_SubawardBudget-1.2.pdf

69513 RR_OtherProjectInfo-1.1.pdf

69513 RR_Budget-1.1.pdf

69513 RR_KeyPersonExpanded-1.1.pdf

69513 RR_PerformanceSite-1.1.pdf

69513 RR_SubawardBudget-1.2.pdf

2025-07-12T14:18:05-05:00

Share This Post, Choose Your Platform!

About the Author: